US Broker Ratings

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 75% Revenue Growth in the Healthcare Sector

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology space, is drawing attention with its robust revenue growth amidst a challenging market environment. As a company focused..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Deep Dive into a High-Potential Biotech with 52% Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising pipeline and substantial potential upside. With a market capitalization..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and 10% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates at the forefront of the Diagnostics & Research industry. With a market capitalization of $20.84 billion, Labcorp..

AbbVie Inc. (ABBV) Investor Outlook: Exploring a 12.63% Potential Upside in the Healthcare Giant

AbbVie Inc. (NYSE: ABBV), a leading research-based biopharmaceutical company, has captured the attention of investors with its impressive market presence and a significant potential upside. With a market capitalization of..

BeOne Medicines Ltd. (ONC): Investor Outlook Reveals 35.69% Potential Upside in Cancer Treatment Innovations

BeOne Medicines Ltd. (ONC), a Swiss biotechnology firm specializing in oncology, is capturing investor attention with a promising 35.69% potential upside. The company, formerly known as BeiGene, Ltd., has been..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 16.88% Potential Upside in Health Information Services

Doximity, Inc. (DOCS) positions itself as a pivotal player within the healthcare sector, specifically in the health information services industry. With a robust market capitalization of $9.78 billion, this San..

Alcon Inc. (ALC) Stock Analysis: Unpacking a 22.48% Potential Upside for Investors

Alcon Inc. (NYSE: ALC), a titan in the healthcare sector with a special focus on medical instruments and supplies, offers a notable opportunity for investors seeking exposure to the eye..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating a 21.74% Potential Upside Amid Robust Revenue Growth

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, commands attention with its innovative products addressing chronic and life-threatening diseases. Headquartered..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Through Challenges with a 29.53% Upside Potential

Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the diagnostics and research sector, captivating investors with its innovative genomic and sequencing solutions. Despite recent challenges reflected in its..

Centene Corporation (CNC) Stock Analysis: Exploring a 38.37% Upside Potential Amid Healthcare Growth

Investors eyeing the healthcare sector might find Centene Corporation (NYSE: CNC) an intriguing prospect given its robust market positioning and significant upside potential. With a market capitalization of $28.08 billion,..

argenx SE (ARGX) Stock Analysis: Strong Growth Potential with 33% Upside and Robust Buy Ratings

argenx SE (ARGX), a Netherlands-based biotechnology company, continues to capture investor interest with its innovative approach to treating autoimmune diseases. With a market capitalization of $35.21 billion, argenx has established..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Market Challenges with a 31.56% Upside Potential

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, specializes in providing mission-critical products and services to diverse industries, including biopharma, healthcare, education, and advanced technologies. Despite recent..

Humana Inc. (HUM) Investor Outlook: Exploring a 30.91% Upside Potential in Healthcare Plans

Humana Inc. (NYSE: HUM), a prominent player in the U.S. healthcare plans industry, is currently positioned at an intriguing juncture for investors, offering a potential upside of 30.91% based on..

Revvity, Inc. (RVTY) Investor Outlook: Navigating a 38% Potential Upside in the Lucrative Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a stalwart in the diagnostics and research industry, is making waves in the healthcare sector with an impressive market capitalization of $10.66 billion. Formerly known as..

Waters Corporation (WAT) Stock Analysis: A Healthcare Powerhouse with 11% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the Diagnostics & Research industry within the healthcare sector, continues to capture the interest of investors due to its robust performance metrics..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 79.58% Potential Upside Amidst Market Challenges

Investors eyeing opportunities in the biotechnology sector might find Moderna, Inc. (NASDAQ: MRNA) a compelling yet complex investment case. The company, well-known for its pioneering work in messenger RNA (mRNA)..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 7.78% Potential Upside in the Diagnostics & Research Space

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable player in the global healthcare sector, specifically within the diagnostics and research industry. Headquartered in Columbus, Ohio, this company has carved..

Hologic, Inc. (HOLX) Stock Analysis: A Healthcare Powerhouse with an 8% Upside Potential

Hologic, Inc. (NASDAQ: HOLX) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its focus on women’s health, Hologic has established..

Biogen Inc. (BIIB) Stock Analysis: A Glimpse into the 32% Potential Upside

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, presents an intriguing proposition for investors, underscored by its promising therapies for neurological and neurodegenerative diseases. Based in Cambridge, Massachusetts,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Potential 37.78% Upside Sparks Investor Interest

Teva Pharmaceutical Industries (TEVA), a prominent player in the healthcare sector, is making waves among investors due to its substantial potential upside of 37.78%. Headquartered in Tel Aviv, Israel, Teva..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds